Updated:
OV Principal Investments
Michael Kim's OV Principal Investments runs a biotech-heavy portfolio sourced from Johns Hopkins labs, with co-investments in companies like D&D Pharmatech.
OV Principal Investments
OV Principal Investments is a US-based investment company with a focus on North America. It is headquartered in Dover.
General information
Firm type
Generalist
Location
Region
North America
Country
United States
City
Dover
Corporate office
Dover, DE, United States
Principals
Michael S. Kim
Founder and CEO
Joshua Schwab
Partner and COO
Sector focus
Frequently asked questions
How does OV Principal Investments source its life-science deals?
OV taps a direct pipeline from Johns Hopkins Medical School, where faculty-founded startups like Valted Seq and Plenary.AI originate from academic labs. The firm co-invests alongside strategic partners such as DongKoo Bio & Pharma Co. and operates alongside scientific founders, including extracellular-vesicle researcher Takahiro Ochiya, who co-founded Evia Life Sciences with Michael Kim.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: